EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor

Hideaki Yano iD, Rezvan Chitsazi, Christopher Lucaj, Phuong Tran, Alexander F Hoffman, Michael H Baumann iD, Carl R Lupica, Lei Shi iD

ACS Chemical Neuroscience · 2023

DOI: 10.1021/acschemneuro.3c00530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von Hideaki Yano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Center for Drug Discovery, N…. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists, Cannabinoids. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, Intramural NIH HHS, Brain and Behavior Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cannabinoid Receptor AgonistsCannabinoidsHumansReceptor, Cannabinoid, CB1DronabinolReceptor, Cannabinoid, CB2

Stichwörter der Autor:innen

bioluminescence resonance energy transfercannabinoid receptor 1molecular dynamicssynthetic cannabinoids

Substanzen

Cannabinoid Receptor Agonists5F-MDMB-PICAReceptor, Cannabinoid, CB1CannabinoidsDronabinolReceptor, Cannabinoid, CB2

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States.
  • Computational Chemistry and Molecular Biophysics Section, National Institutes of Health, Baltimore, Maryland 21224, United States.
  • Electrophysiology Research Section, National Institutes of Health, Baltimore, Maryland 21224, United States.
  • Designer Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, United States.

ORCID-Profile: Hideaki Yano, Michael H Baumann, Lei Shi

Förderung

  • NIDA NIH HHS
  • Intramural NIH HHS
  • Brain and Behavior Research Foundation
  • National Institute on Drug Abuse

Zitieren

APA

Yano, H., Chitsazi, R., Lucaj, C., Tran, P., Hoffman, A. F., Baumann, M. H., Lupica, C. R., & Shi, L. (2023). Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00530

Vancouver

Yano H, Chitsazi R, Lucaj C, Tran P, Hoffman AF, Baumann MH, et al. Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00530

BibTeX
@article{Yano2023,
  author = {Yano, Hideaki and Chitsazi, Rezvan and Lucaj, Christopher and Tran, Phuong and Hoffman, Alexander F and Baumann, Michael H and Lupica, Carl R and Shi, Lei},
  title = {Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor},
  journal = {ACS Chemical Neuroscience},
  year = {2023},
  doi = {10.1021/acschemneuro.3c00530}
}
Kostenlos starten →